Obinutuzumab in allogeneic transplantation for CLL and Richter’s transformation in the age of targeted therapies

Saved in:
Bibliographic Details
Main Authors: Pflug, Natali (Author) , Chakupurakal, Geothy (Author) , Fink, Anna-Maria (Author) , Robrecht, Sandra (Author) , Herling, Marco (Author) , Cramer, Paula (Author) , Holtick, Udo (Author) , Theurich, Sebastian (Author) , Schetelig, Johannes (Author) , Fischer, Kirsten (Author) , Ritgen, Matthias (Author) , Scheid, Christoph (Author) , Eichhorst, Barbara (Author) , Dreger, Peter (Author) , Hallek, Michael (Author) , Bergwelt, Michael von (Author)
Format: Article (Journal) Editorial
Language:English
Published: Nov 12, 2021
In: HemaSphere
Year: 2021, Volume: 5, Issue: 12, Pages: 1-4
ISSN:2572-9241
DOI:10.1097/HS9.0000000000000664
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/HS9.0000000000000664
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/hemasphere/Fulltext/2021/12000/Obinutuzumab_in_Allogeneic_Transplantation_for_CLL.2.aspx
Get full text
Author Notes:Natali Pflug, Geothy Chakupurakal, Anna-Maria Fink, Sandra Robrecht, Marco Herling, Paula Cramer, Udo Holtick, Sebastian Theurich, Johannes Schetelig, Kirsten Fischer, Matthias Ritgen, Christof Scheid, Barbara Eichhorst, Peter Dreger, Michael Hallek, Michael von Bergwelt-Baildon, on behalf of the German CLL study group
Description
Item Description:Gesehen am 07.01.2022
Physical Description:Online Resource
ISSN:2572-9241
DOI:10.1097/HS9.0000000000000664